Drug intelligence / Profile preview

diallyl tetrasulfide

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Diallyl tetrasulfide is an **organosulfur compound** found in garlic (Allium sativum) as part of a family of diallyl polysulfides. Its structure consists of two allyl groups linked by a chain of four sulfur atoms. Diallyl tetrasulfide is a metabolic product of allicin and other polysulfides in garlic. It has been noted in research for its potential **anticancer, antioxidant, anti-inflammatory, and antimicrobial properties** similar to related trisulfide and disulfide analogs. The anti-cancer action is thought to involve induction of apoptosis, regulation of cell cycle arrest, modulation of metabolizing enzymes, and inhibition of invasion/metastasis pathways. Mechanistically, diallyl tetrasulfide is also recognized as a **hydrogen sulfide (H2S) donor**, modulating redox status and signaling in cells, and may engage targets involved in cell death, inflammation, and detoxification pathways. Primary studies denote activity in a variety of preclinical models, but there is no pharmaceutical use or approved indication for this compound.

Other names
diallyl tetrasulfide
02

Targets

TUBB (Tubulin (alpha and beta subunits))CDC25C (Cell division cycle 25C phosphatase)

Beyond the preview

Go deeper on diallyl tetrasulfide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diallyl tetrasulfide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call